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Abstract 
Background To determine the frequency of 
Enteriobacteriaceae species and resistance pattern 
from clinical isolates  
Methods: In this descriptive study,500 samples 
were collected from the patients showing signs and 
symptoms of bacterial infection and isolates were 
screened  for primary selection. These specimens 
(n=500) were divided into four groups: (a) 200 
samples of urine were taken from UTI suspected 
patients, (b) 150 samples of pus were taken from 
wounds, irrespective of its site, (c) 100 samples were 
taken from respiratory tract (tracheal aspirates and 
sputum) and (d) 50 samples of blood were taken 
from suspected patients of septicemia. After 
overnight incubation, established microbiological 
methods, which included colonial morphology, 
gram’s staining and biochemical characteristics were 
used for identification. E. coli ATCC 25922 was used 
as quality control strain for the antimicrobial 
sensitivity.Antimicrobial susceptibility testing of the 
isolated organisms was performed by the disk 
diffusion technique. 
Results: From amongst (402) organisms, 200 
(49.75%) turned out to be Enterobacteriaceae while 
Escherichia coli was leading pathogen (65%). There 
was an increase in resistance against cephalosporin 
3rd and 4th generation (upto74%). The lowest 
resistance was observed against Amikacin and 
Carbapenems. 
Conclusion: There is a  surge of infections caused 
by Enterobacteriaceae and resistant strains are also 
increasing. 
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Introduction 
   Enterobacteriaceae fall within the domain bacteria, 
phylum Proteobacteria, class Gammaproteobacteria, 
order Enterobacteriales. They are Gram-negative, rod 
shaped, non-spore-forming, facultative anaerobes that 
ferment glucose and other sugars, are motile by virtue 
of peritrichous flagella or nonmotile, reduce nitrate to  
nitrite, and produce catalase but do not produce 
oxidase.1    
   Enterobacteriaceae contain more than 100 species 
that are inhabitants of human and animal intestine. 
Pathogenic species cause pneumonia, cystitis, 
pyelonephritis, septicemia, peritonitis, meningitis and 
device-associated infections.2, 3  These are estimated to 
be responsible for approximately 100,000 deaths each 
year in the US only and account for about half of all 
the clinically significant bacteria isolated by hospital 
laboratories.2,4 Enterobacteriaceae members have the 
tendency to spread easily between humans (hand 
carriage, contaminated food and water) and to acquire 
genetic material through horizontal gene transfer, 
mediated by plasmids and transposons.3 Since 2000, 
spread of community-acquired enterobacterial isolates 
(E. coli) that produce extended-spectrum β-lactamases 
(ESBLs) has been reported worldwide3. The 
prevalence of antibiotic resistance in family 
Enterobacteriaceae continues to rise.5Gram-negative 
bacterial resistance possibly equals or over takes that 
of gram positive bacterial resistance and has prompted 
calls for similar infection control measures to reduce 
their dissemination.6 
 
Patients and Methods 
     This descriptive study was conducted in the 
Department of Microbiology, Basic Medical Sciences 
Institute, Jinnah Postgraduate Medical Centre (JPMC), 
Karachi, from January 2011 to December 2011. Sample 
size for frequency in a population was calculated by 
Open EPI, Calculator and confidence level was set at 
80%. The reference study was Khan et al., 20107. The 
calculated sample size was 495.Irrespective of age or 
sex 500 clinical samples were collected by simple 
random method from the patients showing signs and 
symptoms of bacterial infection and isolates were 
screened for primary selection. The subjects included 
in this study were of both sexes and age was ranging 
from15 years to 80 years. The clinical samples were 
collected from the patients admitted in various units of 
JPMC. After taking necessary aseptic measures, the 
samples were collected and necessary data was filled  
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accordingly. These 500 specimens were divided into 
four groups: (a) 200 samples of urine were taken from 
UTI suspected patients, (b) 150 samples of pus were 
taken from wounds, irrespective of its site, (c) 100 
samples were taken from respiratory tract (tracheal 
aspirates and sputum) and (d) 50 samples of blood 
were taken from suspected patients of septicemia. 
    Pus and respiratory secretions were inoculated on 
Blood agar and MacConkey agar. The respiratory 
secretions were additionally inoculated on Chocolate 
and Sabouraud Dextrose Agar (SDA). The urine was 
inoculated on Cysteine Lactose Electrolyte deficient 
(CLED) agar. These plates were incubated aerobically 
at 35±2ºC for 24 hrs. Inoculated blood culture bottles 
were incubated for 24 to 48 hours (and even up to one 
week if need be) at 37ºC and then examined for 
turbidity (showing positive growth). After overnight 
incubation, established microbiological methods, 
which included  colonial morphology, gram staining 
and biochemical characteristics were used for 
identification.8.  E. coli ATCC 25922 was used as 
quality control strain for the antimicrobial 
sensitivity.Antimicrobial susceptibility testing of the 
isolated organisms was performed by the disk 
diffusion technique .9  
 
Results 
     The subjects included in this study were of both 
sexes and age was ranging from15 years to 80 years. 
Out of 500 samples, 64% were received from the 
surgical wards and ICUs; whereas 36% were collected 
from Medical wards and ICUs. Out of 500 samples 
48.2% samples were collected from males while 51.8% 
were taken from females. 
Table 1:Distribution of different groups of 
microorganisms (n=402) 
Organism Number Percent (%) 
Enteriobacteriaceae 200 49.75 
Other Gram-ve bacteria* 76 18.90 
Gram-positive 116 28.86 
Yeast 10 2.49 
Total 402 100 
  *Other than Enterobacteriaceae 
    The 402 microorganisms were isolated from culture 
positive samples 332(66.4%). Enterobacteriaceae 
(49.75%) was commonest (Table 1). Out of all 
enterobactericeae, E.coli was the commonest (65.5%). 
Maximum isolates were from urine (82.16%) (Table 
2).Ampicillin, Trimethoprim-Sulphamethoxazole 
(SXT) and cephalothin (CL) showed 80-100% 
resistance in Enterobacteriaceae. 
Table 2:Frequency of enterobacteriaceae species 
from positive specimens (n=200) 
Enteriobacteriaceae 
species 
Nature of specimen Total (%) 
 
200 
Urine 
(157) 
Pus 
(132) 
Respiratory 
secretions 
(95) 
Blood 
(18) 
Escherichia coli 98 (62.42) 20(15.15) 10(10.5) 3(16.66) 131(65.5) 
Klebsiella 
pneumoniae 
15(9.55) 10(7.57) 15(15.78) 2(11.11) 42(21.0) 
Klebsiella oxytoca 2(1.27)    2(1.0) 
Proteus mirabilis 7(4.45) 2(1.51)   9(4.5) 
Proteus vulgaris 1(0.63)    1(0.5) 
Citrobacter 
freundii, 
 2(1.51)   2((1.0) 
Enterobacter 
cloacae 
4(2.54) 6(4.54)  1(5.55) 11(5.5) 
Provendicia 
stuartii 
1(0.63)    1(0.5) 
Serratia 
marcescens 
1(0.63)    1(0.5) 
Total (%) 129(82.16) 40(30.30) 25(26.31) 6(33.33) 200(49.75) 
 
Table-3:Anitimicrobial resistance patteren(%) 0f 
enterobacteriaceae species 
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Ampicillin 97 100 100 100 100 100 100 100 0 
Amoxicillin-clavulanic 
acid 
60
.0 
83 50 77 0 54 50 0 0 
Piperacillin-
tazobactam 
20 35 0 11 0 18 0 0 0 
Aztreonam 76 83 50 22 0 54 50 0 0 
Cephalothin 93 95 100 100 100 100 100 100 0 
Cefuroxime 83 88 50 77 0 54 50 0 0 
Ceftotaxime 74 81 50 33 0 54 50 0 0 
Ceftazidime 73 83 50 33 0 54 50 0 0 
Ceftriaxone 74
.8
0 
81 50 33 0 54 50 0 0 
Cefepime 70 76 50 22 0 54 50 0 0 
Ofloxacin 74 47 50 33 0 27 50 0 0 
Ciprofloxacin 73 45 50 33 0 27 50 0 0 
Gentamicin 53 59 50 22 0 36 50 0 0 
Amikacin 11 28 0 11 0 18 0 0 0 
Trimethoprim-
sulfamethoxazole 
83 83 100 77 100 54 0 100 100 
Imipenem 4 9. 0 11 0 9 0 0 0 
Meropenem 4 9 0 11 0 9 0 0 0 
Colistin 0 0 0 0 0 0 0 0 0 
Tegecyline 3 4 0 11 0 9 0 0 0 
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Secondly Piperacillin/ Tazobactam (TZP) and 
Amikacin (AK) showed less than 20% resistance in 
Enterobacteriaceae and no resistance was seen against 
colistin (CT) and Polymixin B (PB). The 3-9% 
resistance was recorded against Tigecycline. Out of 
200 isolates 6% were resistant to carbapenem group 
and these were E. coli 4.58% out of 131, K.pneumoniae 
9.52% out of 42, E. cloacae 9% out of 11and P. mirabilis 
11% out of 9 (Table 3). 
 
Discussion 
     The increasing frequency of antibiotic resistant in 
Enterobacteriaceae is a major concern to human health. 
This significantly limits treatment options for life-
threatening infections. The high levels of ESBL 
production is noticed among Enterobacteriaceae in 
Pakistan, especially documented for E. coli and K. 
pneumoniae(40%).10 Carbapenems are the cornerstone 
of therapy for patients with serious infections caused 
by ESBL-producing organisms. 10-12 
    Out of 200 Enterobacteriaceae most common 
isolated organism was E. coli (65.5%), K. pneumoniae 
(21%), Proteus spp. (5%), C. freundii (1.0%), and E. 
cloacae (5.5%). According to Riaz et al (2012)  who 
reported that the common isolates from clinical 
samples were E. coli 65% and K. pneumoniae was 
15%, is in close agreement with our study.13 Another 
study done by Basavaraj et al (2011), from India who 
reported that the frequency of isolates was, E. coli 
57.8%, K. pneumoniae 25.6% and Proteus species 6.5%, 
 also supports our finding.14 The similar pattern of 
isolates was also reported by Mulla et al (2011) from 
India. 15 Nazir et al (2011), who reported E. coli and K. 
pneumoniae, were found at higher frequencies in 
clinical specimens and other species of family 
Enterobacteriaceae were found at lower frequencies in 
Pakistan. 16  
Colistin and Tigecycline is the core of therapy 
for carbapenem-resistant Enterobacteriaceae and last 
available active antimicrobial agents. In our study CRE 
were 100% sensitive to colistin which is in strong 
agreement with the findings from Greece, New York 
and northeastern United States (US)  where it was 
reported that in vitro susceptibility to Polymyxins 
among clinical isolates ranged from 90-100%. MDR 
isolates were resistant to all antibiotics except Colistin 
and Tigecycline reported from India, which is also in 
support of our findings.17-19 In present study 
Enterobacteriaceae were 49.75% of the total clinical 
isolates. Out of these 6.0% were Carbapenem Resistant 
Enterobacteriaceae (CRE). The frequency of CRE is 
lower in present study as compared to the other 
countries. 
Conclusion 
1.There is a surge of infections caused by 
Enterobacteriaceae . 
2. Resistant strains of E.coli are emerging. 
3.Ampicillin, Trimethoprim-Sulphamethoxazole and 
cephalothin reveal maximum resistance  
4. Carbepenem is the main stay of treatment against 
extended spectrum beta lactamases  
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